Get research updatesBipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.
Researchers are comparing SEP-4199 CR 200 mg, SEP-4199 CR 400 mg and placebo to find out how the approaches affect depression symptoms in people with bipolarity type I during a depressive episode.
This study ended early.
Multiple locations, including Huntsville
Researchers compared light therapy and placebo to find out how the approaches affected depression symptoms in people with bipolarity.
This study has finished and is no longer accepting participants.
In BeijingResearchers are studying SEP-4199 CR, tracking side effects to assess long-term safety and tolerability in people with bipolarity type I during a depressive episode.
This study ended early.
Multiple locations, including HuntsvilleResearchers compared Riluzole and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.
This study has finished and is no longer accepting participants.
In BaltimoreA Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder
This study has finished and is no longer accepting participants.
In CincinnatiAn Open-Label, Drug-Drug Interaction Study to Evaluate the Effect of Paliperidone Extended-Release on the Steady-State Pharmacokinetics of Valproic Acid in Clinically Stable Subjects With Schizophrenia, Bipolar I Disorder or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including KissimmeeResearchers are studying EmSam, tracking side effects to assess safety and tolerability in people with bipolarity during a depressive episode.
This study ended early.
In New YorkA Double-blind, Placebo-controlled Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence
This study has finished and is no longer accepting participants.
In DallasA Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment of Bipolar Depression
This study has finished and is no longer accepting participants.
In DavisA Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression
This study has finished and is no longer accepting participants.
In Cincinnati
A Prophylactic Trial of Omega-3 Polyunsaturated Fatty Acids in Bipolar Disorder
This study has finished and is no longer accepting participants.
In GalwayResearchers compared Olanzapine Fluoxetine Combination (OFC) and placebo, tracking side effects to assess safety in people with bipolarity type I.
This study has finished and is no longer accepting participants.
Multiple locations, including San DiegoWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.